乳腺癌患者的FAP靶向SPECT/CT与PET/CT显像
本综述聚焦乳腺癌中癌相关成纤维细胞高表达成纤维细胞激活蛋白(FAP)这一靶点,介绍FAP特异性放射性示踪剂联合PET/CT与SPECT/CT在乳腺癌早期检测、分期、治疗反应监测及治疗干预中的潜在价值,并探讨蛋白状态评估的先进技术、早期靶向治疗开发及其他新兴应用。
要点
- 乳腺癌中癌相关成纤维细胞高表达成纤维细胞激活蛋白(FAP),是重要靶点。
- FAP特异性放射性示踪剂联合PET/CT和SPECT/CT在乳腺癌早期检测、分期、治疗反应监测及治疗干预方面有显著潜力。
- FAP靶向显像有望显著提升个体化肿瘤诊疗,改善乳腺癌管理和患者总体结局。
核心结论
- FAP靶向分子显像有望显著提升个体化肿瘤诊疗,从而改善乳腺癌管理和患者总体结局。
研究设计与样本
- 本文为综述,围绕FAP靶向分子显像,探讨蛋白状态评估的先进技术、早期靶向治疗的开发及其他新兴应用。
主要发现
- 乳腺癌中癌相关成纤维细胞高度普遍并表达成纤维细胞激活蛋白(FAP),被视为关键靶点。
- FAP特异性放射性示踪剂与PET/CT和SPECT/CT联合使用,在改善乳腺癌早期检测、分期、治疗反应监测及治疗干预方面具有显著潜力。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Breast cancer presents a significant global health challenge, necessitating continued innovation in diagnostic and therapeutic approaches. Recent advances have led to the identification of cancer-associated fibroblasts, which are highly prevalent in breast cancers and express fibroblast activation proteins (FAPs), as critical targets. FAP-specific radiotracers, when used with PET/CT and SPECT/CT, have significant potential for improving early breast cancer detection, staging, treatment response monitoring, and therapeutic intervention. This review provides insight into FAP-targeted molecular imaging, exploring advanced techniques for protein status assessment, development of early-phase targeted therapies, and other emerging applications. The advent of FAP-targeted imaging stands to significantly enhance personalized oncologic care, leading to improved breast cancer management and overall patient outcomes.
引用
- McGale J, Khurana S, Howell H, et al. FAP-Targeted SPECT/CT and PET/CT Imaging for Breast Cancer Patients. Clin Nucl Med. 2025. PMID: 39780367. doi:10.1097/RLU.0000000000005617
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。